Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines [Globe and Mail, The (Toronto, Canada)]
Vericel Corporation (VCEL)
Last vericel corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vcel.com/investor-relations
Company Research
Source: Globe and Mail, The
VANCOUVER, BC April 6, 2026 /CNW/ -- The global cell therapy manufacturing market is on track to nearly double, from $7.17 billion in 2026 to over $14 billion by 2035 [1] . The science has been proving itself for years. What most of these companies still lack is the production backbone to actually deliver at scale: GMP qualified facilities, traceable cell banks, and manufacturing processes that regulators will sign off on. The FDA accelerated the timeline in early 2026 by formalizing flexible manufacturing and quality control oversight for cell and gene therapies, clearing a path that had stalled the jump from clinical validation to commercial product [2] . Five companies have already crossed key manufacturing thresholds in that transition: Avaí Bio (OTCQB: AVAI), Vericel (NASDAQ: VCEL), Sana Biotechnology (NASDAQ: SANA), Lineage Cell Therapeutics (NYSE-A: LCTX), and Eledon Pharmaceuticals (NASDAQ: ELDN). Read more at newswire.ca This article contains syndicated content. We have
Show less
Read more
Impact Snapshot
Event Time:
VCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCEL alerts
High impacting Vericel Corporation news events
Weekly update
A roundup of the hottest topics
VCEL
News
- Why Smart Money Is Shifting From Clinical Data to Manufacturing LinesPR Newswire
- Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid [Yahoo! Finance]Yahoo! Finance
- Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBridGlobeNewswire
- Vericel (VCEL) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=VCEL&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "buy".MarketBeat
- What Makes Vericel Corporation (VCEL) an Investment Bet? [Yahoo! Finance]Yahoo! Finance
VCEL
Earnings
- 2/26/26 - In-Line
VCEL
Analyst Actions
- 3/10/26 - Leerink Partners
VCEL
Sec Filings
- 4/6/26 - Form 4
- 4/2/26 - Form 144
- 4/1/26 - Form SCHEDULE
- VCEL's page on the SEC website